List of Tables
Table 1. Global Alzheimer’s Therapeutic Market Value Comparison by Type (2024 VS 2031) & (US$ Million)
Table 2. Global Alzheimer’s Therapeutic Market Value by Application (2024 VS 2031) & (US$ Million)
Table 3. Global Alzheimer’s Therapeutic Market Competitive Situation by Manufacturers in 2024
Table 4. Global Alzheimer’s Therapeutic Sales (K Pcs) of Key Manufacturers (2020-2025)
Table 5. Global Alzheimer’s Therapeutic Sales Market Share by Manufacturers (2020-2025)
Table 6. Global Alzheimer’s Therapeutic Revenue (US$ Million) by Manufacturers (2020-2025)
Table 7. Global Alzheimer’s Therapeutic Revenue Share by Manufacturers (2020-2025)
Table 8. Global Market Alzheimer’s Therapeutic Average Price (USD/Pcs) of Key Manufacturers (2020-2025)
Table 9. Global Key Players of Alzheimer’s Therapeutic, Industry Ranking, 2022 VS 2023 VS 2024
Table 10. Global Key Manufacturers of Alzheimer’s Therapeutic, Manufacturing Sites & Headquarters
Table 11. Global Key Manufacturers of Alzheimer’s Therapeutic, Product Type & Application
Table 12. Global Key Manufacturers of Alzheimer’s Therapeutic, Date of Enter into This Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Alzheimer’s Therapeutic by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Alzheimer’s Therapeutic as of 2024)
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global Alzheimer’s Therapeutic Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Table 17. Global Alzheimer’s Therapeutic Sales by Region (2020-2025) & (K Pcs)
Table 18. Global Alzheimer’s Therapeutic Sales Market Share by Region (2020-2025)
Table 19. Global Alzheimer’s Therapeutic Sales by Region (2026-2031) & (K Pcs)
Table 20. Global Alzheimer’s Therapeutic Sales Market Share by Region (2026-2031)
Table 21. Global Alzheimer’s Therapeutic Revenue by Region (2020-2025) & (US$ Million)
Table 22. Global Alzheimer’s Therapeutic Revenue Market Share by Region (2020-2025)
Table 23. Global Alzheimer’s Therapeutic Revenue by Region (2026-2031) & (US$ Million)
Table 24. Global Alzheimer’s Therapeutic Revenue Market Share by Region (2026-2031)
Table 25. North America Alzheimer’s Therapeutic Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 26. North America Alzheimer’s Therapeutic Sales by Country (2020-2025) & (K Pcs)
Table 27. North America Alzheimer’s Therapeutic Sales by Country (2026-2031) & (K Pcs)
Table 28. North America Alzheimer’s Therapeutic Revenue by Country (2020-2025) & (US$ Million)
Table 29. North America Alzheimer’s Therapeutic Revenue by Country (2026-2031) & (US$ Million)
Table 30. Europe Alzheimer’s Therapeutic Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 31. Europe Alzheimer’s Therapeutic Sales by Country (2020-2025) & (K Pcs)
Table 32. Europe Alzheimer’s Therapeutic Sales by Country (2026-2031) & (K Pcs)
Table 33. Europe Alzheimer’s Therapeutic Revenue by Country (2020-2025) & (US$ Million)
Table 34. Europe Alzheimer’s Therapeutic Revenue by Country (2026-2031) & (US$ Million)
Table 35. Asia Pacific Alzheimer’s Therapeutic Revenue by Region: 2020 VS 2024 VS 2031 (US$ Million)
Table 36. Asia Pacific Alzheimer’s Therapeutic Sales by Region (2020-2025) & (K Pcs)
Table 37. Asia Pacific Alzheimer’s Therapeutic Sales by Region (2026-2031) & (K Pcs)
Table 38. Asia Pacific Alzheimer’s Therapeutic Revenue by Region (2020-2025) & (US$ Million)
Table 39. Asia Pacific Alzheimer’s Therapeutic Revenue by Region (2026-2031) & (US$ Million)
Table 40. Latin America Alzheimer’s Therapeutic Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 41. Latin America Alzheimer’s Therapeutic Sales by Country (2020-2025) & (K Pcs)
Table 42. Latin America Alzheimer’s Therapeutic Sales by Country (2026-2031) & (K Pcs)
Table 43. Latin America Alzheimer’s Therapeutic Revenue by Country (2020-2025) & (US$ Million)
Table 44. Latin America Alzheimer’s Therapeutic Revenue by Country (2026-2031) & (US$ Million)
Table 45. Middle East and Africa Alzheimer’s Therapeutic Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 46. Middle East and Africa Alzheimer’s Therapeutic Sales by Country (2020-2025) & (K Pcs)
Table 47. Middle East and Africa Alzheimer’s Therapeutic Sales by Country (2026-2031) & (K Pcs)
Table 48. Middle East and Africa Alzheimer’s Therapeutic Revenue by Country (2020-2025) & (US$ Million)
Table 49. Middle East and Africa Alzheimer’s Therapeutic Revenue by Country (2026-2031) & (US$ Million)
Table 50. Global Alzheimer’s Therapeutic Sales (K Pcs) by Type (2020-2025)
Table 51. Global Alzheimer’s Therapeutic Sales (K Pcs) by Type (2026-2031)
Table 52. Global Alzheimer’s Therapeutic Sales Market Share by Type (2020-2025)
Table 53. Global Alzheimer’s Therapeutic Sales Market Share by Type (2026-2031)
Table 54. Global Alzheimer’s Therapeutic Revenue (US$ Million) by Type (2020-2025)
Table 55. Global Alzheimer’s Therapeutic Revenue (US$ Million) by Type (2026-2031)
Table 56. Global Alzheimer’s Therapeutic Revenue Market Share by Type (2020-2025)
Table 57. Global Alzheimer’s Therapeutic Revenue Market Share by Type (2026-2031)
Table 58. Global Alzheimer’s Therapeutic Price (USD/Pcs) by Type (2020-2025)
Table 59. Global Alzheimer’s Therapeutic Price (USD/Pcs) by Type (2026-2031)
Table 60. Global Alzheimer’s Therapeutic Sales (K Pcs) by Application (2020-2025)
Table 61. Global Alzheimer’s Therapeutic Sales (K Pcs) by Application (2026-2031)
Table 62. Global Alzheimer’s Therapeutic Sales Market Share by Application (2020-2025)
Table 63. Global Alzheimer’s Therapeutic Sales Market Share by Application (2026-2031)
Table 64. Global Alzheimer’s Therapeutic Revenue (US$ Million) by Application (2020-2025)
Table 65. Global Alzheimer’s Therapeutic Revenue (US$ Million) by Application (2026-2031)
Table 66. Global Alzheimer’s Therapeutic Revenue Market Share by Application (2020-2025)
Table 67. Global Alzheimer’s Therapeutic Revenue Market Share by Application (2026-2031)
Table 68. Global Alzheimer’s Therapeutic Price (USD/Pcs) by Application (2020-2025)
Table 69. Global Alzheimer’s Therapeutic Price (USD/Pcs) by Application (2026-2031)
Table 70. Pfizer Inc Company Information
Table 71. Pfizer Inc Description and Business Overview
Table 72. Pfizer Inc Alzheimer’s Therapeutic Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
Table 73. Pfizer Inc Alzheimer’s Therapeutic Product
Table 74. Pfizer Inc Recent Developments/Updates
Table 75. Novartis International AG Company Information
Table 76. Novartis International AG Description and Business Overview
Table 77. Novartis International AG Alzheimer’s Therapeutic Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
Table 78. Novartis International AG Alzheimer’s Therapeutic Product
Table 79. Novartis International AG Recent Developments/Updates
Table 80. Axovant Sciences Ltd Company Information
Table 81. Axovant Sciences Ltd Description and Business Overview
Table 82. Axovant Sciences Ltd Alzheimer’s Therapeutic Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
Table 83. Axovant Sciences Ltd Alzheimer’s Therapeutic Product
Table 84. Axovant Sciences Ltd Recent Developments/Updates
Table 85. Acadia Pharmaceuticals, Inc Company Information
Table 86. Acadia Pharmaceuticals, Inc Description and Business Overview
Table 87. Acadia Pharmaceuticals, Inc Alzheimer’s Therapeutic Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
Table 88. Acadia Pharmaceuticals, Inc Alzheimer’s Therapeutic Product
Table 89. Acadia Pharmaceuticals, Inc Recent Developments/Updates
Table 90. Biotie Therapies Company Information
Table 91. Biotie Therapies Description and Business Overview
Table 92. Biotie Therapies Alzheimer’s Therapeutic Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
Table 93. Biotie Therapies Alzheimer’s Therapeutic Product
Table 94. Biotie Therapies Recent Developments/Updates
Table 95. Astra Zeneca plc Company Information
Table 96. Astra Zeneca plc Description and Business Overview
Table 97. Astra Zeneca plc Alzheimer’s Therapeutic Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
Table 98. Astra Zeneca plc Alzheimer’s Therapeutic Product
Table 99. Astra Zeneca plc Recent Developments/Updates
Table 100. Eli Lilly, Inc Company Information
Table 101. Eli Lilly, Inc Description and Business Overview
Table 102. Eli Lilly, Inc Alzheimer’s Therapeutic Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
Table 103. Eli Lilly, Inc Alzheimer’s Therapeutic Product
Table 104. Eli Lilly, Inc Recent Developments/Updates
Table 105. F. Hoffman Le Roche Company Information
Table 106. F. Hoffman Le Roche Description and Business Overview
Table 107. F. Hoffman Le Roche Alzheimer’s Therapeutic Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
Table 108. F. Hoffman Le Roche Alzheimer’s Therapeutic Product
Table 109. F. Hoffman Le Roche Recent Developments/Updates
Table 110. Merck & Co Company Information
Table 111. Merck & Co Description and Business Overview
Table 112. Merck & Co Alzheimer’s Therapeutic Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
Table 113. Merck & Co Alzheimer’s Therapeutic Product
Table 114. Merck & Co Recent Developments/Updates
Table 115. H. Lundbeck A/S Company Information
Table 116. H. Lundbeck A/S Description and Business Overview
Table 117. H. Lundbeck A/S Alzheimer’s Therapeutic Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
Table 118. H. Lundbeck A/S Alzheimer’s Therapeutic Product
Table 119. H. Lundbeck A/S Recent Developments/Updates
Table 120. Takeda Pharmaceutical Company Ltd Company Information
Table 121. Takeda Pharmaceutical Company Ltd Description and Business Overview
Table 122. Takeda Pharmaceutical Company Ltd Alzheimer’s Therapeutic Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
Table 123. Takeda Pharmaceutical Company Ltd Alzheimer’s Therapeutic Product
Table 124. Takeda Pharmaceutical Company Ltd Recent Developments/Updates
Table 125. Key Raw Materials Lists
Table 126. Raw Materials Key Suppliers Lists
Table 127. Alzheimer’s Therapeutic Distributors List
Table 128. Alzheimer’s Therapeutic Customers List
Table 129. Alzheimer’s Therapeutic Market Trends
Table 130. Alzheimer’s Therapeutic Market Drivers
Table 131. Alzheimer’s Therapeutic Market Challenges
Table 132. Alzheimer’s Therapeutic Market Restraints
Table 133. Research Programs/Design for This Report
Table 134. Key Data Information from Secondary Sources
Table 135. Key Data Information from Primary Sources
Table 136. Authors List of This Report
List of Figures
Figure 1. Product Picture of Alzheimer’s Therapeutic
Figure 2. Global Alzheimer’s Therapeutic Market Value Comparison by Type (2020-2031) & (US$ Million)
Figure 3. Global Alzheimer’s Therapeutic Market Share by Type: 2024 & 2031
Figure 4. Memantine Hydrochloride Product Picture
Figure 5. Donepezil Hydrochloride Product Picture
Figure 6. Rivastigmine Product Picture
Figure 7. Galantamine Hydrobromide Product Picture
Figure 8. Global Alzheimer’s Therapeutic Market Value by Application (2020-2031) & (US$ Million)
Figure 9. Global Alzheimer’s Therapeutic Market Share by Application: 2024 & 2031
Figure 10. Hospitals
Figure 11. Clinic
Figure 12. Other
Figure 13. Global Alzheimer’s Therapeutic Revenue, (US$ Million), 2020 VS 2024 VS 2031
Figure 14. Global Alzheimer’s Therapeutic Market Size (2020-2031) & (US$ Million)
Figure 15. Global Alzheimer’s Therapeutic Sales (2020-2031) & (K Pcs)
Figure 16. Global Alzheimer’s Therapeutic Average Price (USD/Pcs) & (2020-2031)
Figure 17. Alzheimer’s Therapeutic Report Years Considered
Figure 18. Alzheimer’s Therapeutic Sales Share by Manufacturers in 2024
Figure 19. Global Alzheimer’s Therapeutic Revenue Share by Manufacturers in 2024
Figure 20. Global 5 and 10 Largest Alzheimer’s Therapeutic Players: Market Share by Revenue in Alzheimer’s Therapeutic in 2024
Figure 21. Alzheimer’s Therapeutic Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
Figure 22. Global Alzheimer’s Therapeutic Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Figure 23. North America Alzheimer’s Therapeutic Sales Market Share by Country (2020-2031)
Figure 24. North America Alzheimer’s Therapeutic Revenue Market Share by Country (2020-2031)
Figure 25. U.S. Alzheimer’s Therapeutic Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 26. Canada Alzheimer’s Therapeutic Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 27. Europe Alzheimer’s Therapeutic Sales Market Share by Country (2020-2031)
Figure 28. Europe Alzheimer’s Therapeutic Revenue Market Share by Country (2020-2031)
Figure 29. Germany Alzheimer’s Therapeutic Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 30. France Alzheimer’s Therapeutic Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 31. U.K. Alzheimer’s Therapeutic Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 32. Italy Alzheimer’s Therapeutic Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 33. Russia Alzheimer’s Therapeutic Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 34. Asia Pacific Alzheimer’s Therapeutic Sales Market Share by Region (2020-2031)
Figure 35. Asia Pacific Alzheimer’s Therapeutic Revenue Market Share by Region (2020-2031)
Figure 36. China Alzheimer’s Therapeutic Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 37. Japan Alzheimer’s Therapeutic Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 38. South Korea Alzheimer’s Therapeutic Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 39. India Alzheimer’s Therapeutic Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 40. Australia Alzheimer’s Therapeutic Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 41. Taiwan Alzheimer’s Therapeutic Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 42. Indonesia Alzheimer’s Therapeutic Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 43. Thailand Alzheimer’s Therapeutic Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 44. Malaysia Alzheimer’s Therapeutic Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 45. Philippines Alzheimer’s Therapeutic Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 46. Latin America Alzheimer’s Therapeutic Sales Market Share by Country (2020-2031)
Figure 47. Latin America Alzheimer’s Therapeutic Revenue Market Share by Country (2020-2031)
Figure 48. Mexico Alzheimer’s Therapeutic Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 49. Brazil Alzheimer’s Therapeutic Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 50. Argentina Alzheimer’s Therapeutic Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 51. Middle East and Africa Alzheimer’s Therapeutic Sales Market Share by Country (2020-2031)
Figure 52. Middle East and Africa Alzheimer’s Therapeutic Revenue Market Share by Country (2020-2031)
Figure 53. Turkey Alzheimer’s Therapeutic Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 54. Saudi Arabia Alzheimer’s Therapeutic Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 55. UAE Alzheimer’s Therapeutic Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 56. Global Sales Market Share of Alzheimer’s Therapeutic by Type (2020-2031)
Figure 57. Global Revenue Market Share of Alzheimer’s Therapeutic by Type (2020-2031)
Figure 58. Global Alzheimer’s Therapeutic Price (USD/Pcs) by Type (2020-2031)
Figure 59. Global Sales Market Share of Alzheimer’s Therapeutic by Application (2020-2031)
Figure 60. Global Revenue Market Share of Alzheimer’s Therapeutic by Application (2020-2031)
Figure 61. Global Alzheimer’s Therapeutic Price (USD/Pcs) by Application (2020-2031)
Figure 62. Alzheimer’s Therapeutic Value Chain
Figure 63. Channels of Distribution (Direct Vs Distribution)
Figure 64. Bottom-up and Top-down Approaches for This Report
Figure 65. Data Triangulation
Figure 66. Key Executives Interviewed
